Navigation Links
HealthSouth to Present at J.P. Morgan Healthcare Global High Yield & Leveraged Finance Conference
Date:1/26/2009

BIRMINGHAM, Ala., Jan. 26 /PRNewswire-FirstCall/ -- HealthSouth Corporation (NYSE: HLS) today announced it will participate in the J.P. Morgan Healthcare Global High Yield & Leveraged Finance Conference on Feb. 2-4, 2009, in Miami Beach, Fla.

HealthSouth Chief Financial Officer John Workman will be speaking on Tuesday, Feb. 3, at 8 a.m. EST. The presentation will be webcast live and may be accessed via the Investor Information section on the company's Web site at www.healthsouth.com.

About HealthSouth

HealthSouth is the nation's largest provider of inpatient rehabilitation services. Operating in 26 states across the country and in Puerto Rico, HealthSouth serves more than 250,000 patients annually through its network of inpatient rehabilitation hospitals, long-term acute care hospitals, outpatient rehabilitation satellites, and home health agencies. HealthSouth strives to be the nation's preeminent provider of inpatient rehabilitation services and can be found on the Web at www.healthsouth.com.

    Media Contact
    Andy Brimmer, 205-410-2777
    Investor Relations Contact
    Mary Ann Arico, 205-969-6175
    maryann.arico@healthsouth.com

'/>"/>
SOURCE HealthSouth Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. HealthSouth Announces Date of 2008 Fourth Quarter and Year-End Earnings Conference Call
2. HealthSouth Reports Results for Third Quarter Ended September 30, 2008
3. HealthSouth Reaffirms Business Fundamentals and Full Year 2008 Guidance
4. HealthSouth Announces Plans to Build New Hospital in Arizona
5. HealthSouth to Hold Investor Meeting November 10, 2008
6. HealthSouth Finalizes Acquisition of Rehabilitation Unit at Medical Center of Arlington
7. HealthSouth Finalizes Purchase of New Jersey Rehabilitation Hospital
8. HealthSouth Appoints Mary Ann Arico as SVP - Investor Relations and Corporate Communications
9. HealthSouth To Acquire Rehabilitation Unit at Medical Center of Arlington
10. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
11. HealthSouth to Present at the 2008 Citigroup Global Healthcare Conference and Jefferies 2nd Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2017)... Tampa, Fla. (PRWEB) , ... June 24, 2017 ... ... Fla., is now offering genetic testing for medications in select Florida and Texas ... of pharmacogenomics. , This new application of genetic testing recognizes the role ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Rhode Island ... Care Management Alerts and Dashboards, an innovative new service enabling healthcare providers to ... Care Management Alerts and Dashboards provide near real-time data about patients admitted to ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Military Officers Association of America (MOAA) announced ... Veterans Affairs, retired Marine Col. Thomas G. Bowman. , Bowman currently serves as the ... an intimacy with the issues and challenges veterans face with the VA. Following a ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... The Aesthetic ... facelift . Dr. Talei has come up with a proprietary technique that he calls ... lifts tissues that have dropped. For all ages, patients can expect to look refreshed, ...
(Date:6/23/2017)... Santa Monica, CA (PRWEB) , ... June 23, 2017 , ... ... PureLife as the endorsed amalgam separator supplier for CDA members. As part of the ... a reduced price of $99, saving more than $400 off the retail value. This ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... ALTO, Calif. , June 9, 2017 ... device company focused on the design, manufacture, sale and ... the market on the progress of its commercial roll-out ... is now available in more than one hundred (100) ... AeroForm offers a needle-free alternative for ...
(Date:6/7/2017)... , June 7, 2017 Endo International ... June 7, 2017, the Hon. Joseph R. Goodwin ... of West Virginia , entered a ... Inc. Pelvic Repair System Products Liability Litigation (the "MDL") ... MDL cases to provide expert disclosures on specific causation ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
Breaking Medicine Technology: